Loading…

Arg-vasopressin increases proliferation of human osteoblast-like cells and decreases production of interleukin-6 and macrophage colony-stimulating factor

Patients with arginine-vasopressin (AVP) deficiency have been reported to have a decreased bone mass. The mechanism behind this is not known. In this study, the effects of AVP on primary human osteoblast-like (hOB) cells and SaOS-2 cells were investigated. Cell proliferation was measured by [ 3H]thy...

Full description

Saved in:
Bibliographic Details
Published in:Regulatory peptides 2004-09, Vol.121 (1), p.41-48
Main Authors: Lagumdzija, Alena, Bucht, Elisabet, Stark, André, Hulting, Anna-Lena, Petersson, Maria
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Patients with arginine-vasopressin (AVP) deficiency have been reported to have a decreased bone mass. The mechanism behind this is not known. In this study, the effects of AVP on primary human osteoblast-like (hOB) cells and SaOS-2 cells were investigated. Cell proliferation was measured by [ 3H]thymidine incorporation or a commercially available kit (EZ4U), and protein synthesis by [ 3H]proline incorporation. In addition, the production of interleukin-6 (IL-6) and macrophage colony-stimulating factor (M-CSF) in hOB cells was determined. AVP at 10–100 pmol/l increased cell proliferation in hOB and SaOS-2 cells ( p
ISSN:0167-0115
1873-1686
DOI:10.1016/j.regpep.2004.04.002